Ishikawa Kosuke, Yamamoto Yuhei, Funayama Emi, Furukawa Hiroshi, Sasaki Satoru
Department of Plastic and Reconstructive Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Department of Plastic and Reconstructive Surgery, Aichi Medical University, Nagakute, Japan.
Adv Wound Care (New Rochelle). 2019 Jun 1;8(6):246-255. doi: 10.1089/wound.2018.0835. Epub 2019 Jun 6.
In Klippel-Trenaunay syndrome (KTS), management of a wound in the affected limb can be difficult because of the underlying vascular malformations present. This review describes the characteristics of KTS with wound complications in light of the genetic and molecular mechanisms of the disease. KTS is a slow-flow combined vascular malformation characterized by the triad of capillary malformation, venous malformation with or without lymphatic malformation, and limb overgrowth. KTS is encompassed within the phosphatidylinositol-4,5-bisphosphate3-kinase catalytic subunit alpha ()-related overgrowth spectrum (PROS), having recently been linked to activating mutations in the gene. This clearly has implications for both molecular diagnosis and potential treatment strategies for the disease. KTS should be distinguished from Parkes Weber syndrome, a fast-flow-type combined vascular malformation with limb overgrowth. Individualized management is needed for KTS and should be focused on the treatment of symptoms. Targeted therapies that inhibit the phosphoinositide 3-kinase signaling pathway are a potential treatment option for PROS.
在克-特综合征(KTS)中,由于存在潜在的血管畸形,受累肢体伤口的处理可能会很困难。本综述根据该疾病的遗传和分子机制,描述了伴有伤口并发症的KTS的特征。KTS是一种低流速复合型血管畸形,其特征为毛细血管畸形、伴有或不伴有淋巴管畸形的静脉畸形以及肢体过度生长三联征。KTS属于磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基α(PIK3CA)相关过度生长谱系(PROS),最近已与PIK3CA基因的激活突变相关联。这显然对该疾病的分子诊断和潜在治疗策略都有影响。KTS应与帕克斯·韦伯综合征相鉴别,后者是一种伴有肢体过度生长的高流速复合型血管畸形。KTS需要个体化管理,且应侧重于症状治疗。抑制磷酸肌醇3-激酶信号通路的靶向治疗是PROS的一种潜在治疗选择。